Global Orthopedic Regenerative Medicine Market to 2028 – Featuring Anika Therapeutics, Baxter International and Stryker Among Others -…

DUBLIN, February 04, 2022--(BUSINESS WIRE)--The "Orthopedic Regenerative Medicine Market, by Treatment Type, by Disease Indication, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Regenerative medicines can be consider as manufacturing of pharmaceuticals for the regrowth of cells, replacing damaged cells, organs, or tissues .The developing methods for medicines includes the generation, tissue engineering, and therapeutic stem cells and production of artificial organs.

Regenerative orthopedic medicines can help in healing damaged tissues, and improve the discomfort and pain which occurred due to musculoskeletal diseases. These regenerative medicines can be developed by using stem cells, plasma-rich sources, biological tissues, and bone marrow. Orthopedic regenerative medicines help in healing injuries of ligament, tendon, bone, spinal disc, muscle, cartilage, and musculoskeletal tissues.

Market players are indulged in receiving approvals from regulatory authorities for the treatment of orthopedic diseases, which is expected to drive the growth of the global orthopedic regenerative medicine market over the forecast period. For instance, on June 28, 2021, Curasan AG, a company which produce regenerative medicines, has received approval from U.S. Food and Drug Administration (FDA) and The National Health Surveillance Agency (ANVISA) Brazilian regulatory agency for CERASORB Foam for use with antibiotics which is a ?-TCP collagen matrix which use for delivering antimicrobials to wound surface to inhibit microbes capable of healing. The major use of this foam is minimizing the risk of reinfection of the infected area by combining it with antibiotics.

Increasing inorganic activities by market players such as collaborations, partnerships, and agreements is expected to drive the growth of the global orthopedic regenerative medicine market over the forecast period. For instance, on January 14, 2021, Bone Therapeutics, which is a manufacturer of cell therapy products, signed partnership with Rigener and, a company which develops and produces cGMP products, used for cell-gene therapy. The aim of this partnership was to develop products based on bone therapeutics by expanding research for therapeutic portfolio. This partnership will be focused on augmented bone forming cells that are programmed for specific task and by studying the new mechanisms of action for gene modifications for orthopedic regenerative medicines.

Story continues

Company Profiles

Ortho Regenerative Technologies Inc.

Personalized stem cells Inc.

Anika Therapeutics Inc.

Arthrex Inc.

Baxter International Inc.

Conmed Corporation

Aziyo Biologics

Curasan Inc.

Swiss biomed Orthopedics AG

Octane Medical Inc.

Stryker Corporation

Carmell Therapeutics Corporation

Zimmer Holdings

Smith & Nephew plc.

NuVasive Inc.

Key features of the study:

This report provides an in-depth analysis of the global orthopedic regenerative medicine market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year.

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players

It profiles leading players in the global orthopedic regenerative medicine market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global orthopedic regenerative medicine market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global orthopedic regenerative medicine market

Key Topics Covered:

1. Research Objectives and Assumptions

2. Market Overview

Report Description

Market Definition and Scope

Executive Summary

Market Snippet, By Treatment Type

Market Snippet, By Disease Indication

Market Snippet, By End User

Market Snippet, By Region

Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

4. COVID - 19 Impact Analysis

5. Global Orthopedic Regenerative Medicine Market, By Treatment Type, 2017 - 2028 (US$ Million)

6. Global Orthopedic Regenerative Medicine Market, By Disease Indication , 2017 - 2028 (US$ Million)

7. Global Orthopedic Regenerative Medicine Market, By End User, 2017 - 2028 (US$ Million)

8. Global Orthopedic Regenerative Medicine Market, By Region, 2017 - 2028 (US$ Million)

9. Competitive Landscape

10. Section

For more information about this report visit https://www.researchandmarkets.com/r/c8xqzo

View source version on businesswire.com: https://www.businesswire.com/news/home/20220204005208/en/

Contacts

ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

Continue reading here:
Global Orthopedic Regenerative Medicine Market to 2028 - Featuring Anika Therapeutics, Baxter International and Stryker Among Others -...